Simultaneous breakdown of multiple antibiotic resistance mechanisms in S. aureus

FASEB J. 2013 Dec;27(12):4834-43. doi: 10.1096/fj.13-237610. Epub 2013 Aug 22.

Abstract

In previous studies, the oligo-acyl-lysyl (OAK) C12(ω7)K-β12 added to cultures of gram-positive bacteria exerted a bacteriostatic activity that was associated with membrane depolarization, even at high concentrations. Here, we report that multidrug-resistant Staphylococcus aureus strains, unlike other gram-positive species, have reverted to the sensitive phenotype when exposed to subminimal inhibitory concentrations (sub-MICs) of the OAK, thereby increasing antibiotics potency by up to 3 orders of magnitude. Such chemosensitization was achieved using either cytoplasm or cell-wall targeting antibiotics. Moreover, eventual emergence of resistance to antibiotics was significantly delayed. Using the mouse peritonitis-sepsis model, we show that on single-dose administration of oxacillin and OAK combinations, death induced by a lethal staphylococcal infection was prevented in a synergistic manner, thereby supporting the likelihood for synergism to persist under in vivo conditions. Toward illuminating the molecular basis for these observations, we present data arguing that sub-MIC OAK interactions with the plasma membrane can inhibit proton-dependent signal transduction responsible for expression and export of resistance factors, as demonstrated for β-lactamase and PBP2a. Collectively, the data reveal a potentially useful approach for overcoming antibiotic resistance and for preventing resistance from emerging as readily as when bacteria are exposed to an antibiotic alone.

Keywords: OAK; host defense peptides; membrane potential; oxacillin; peptidomimetics; synergy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / chemical synthesis
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Dose-Response Relationship, Drug
  • Drug Combinations
  • Drug Resistance, Multiple, Bacterial*
  • Drug Synergism
  • Male
  • Mice
  • Mice, Inbred ICR
  • Oligopeptides / administration & dosage
  • Oligopeptides / chemical synthesis
  • Oligopeptides / pharmacology*
  • Oligopeptides / therapeutic use
  • Oxacillin / administration & dosage
  • Oxacillin / pharmacology*
  • Oxacillin / therapeutic use
  • Penicillin-Binding Proteins / genetics
  • Penicillin-Binding Proteins / metabolism
  • Peritonitis / drug therapy
  • R Factors / drug effects
  • Sepsis / drug therapy
  • Signal Transduction
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / metabolism
  • Transcription, Genetic
  • beta-Lactamases / genetics
  • beta-Lactamases / metabolism

Substances

  • Anti-Bacterial Agents
  • Drug Combinations
  • Oligopeptides
  • Penicillin-Binding Proteins
  • beta-Lactamases
  • Oxacillin